334 related articles for article (PubMed ID: 24493757)
1. Ion channels and transporters in the development of drug resistance in cancer cells.
Hoffmann EK; Lambert IH
Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130109. PubMed ID: 24493757
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of multidrug resistance in cancer.
Gillet JP; Gottesman MM
Methods Mol Biol; 2010; 596():47-76. PubMed ID: 19949920
[TBL] [Abstract][Full Text] [Related]
3. Ion channels and apoptosis in cancer.
Bortner CD; Cidlowski JA
Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130104. PubMed ID: 24493752
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
Pérez-Tomás R
Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
[TBL] [Abstract][Full Text] [Related]
5. Ion channels in the regulation of apoptosis.
Kondratskyi A; Kondratska K; Skryma R; Prevarskaya N
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2532-46. PubMed ID: 25450339
[TBL] [Abstract][Full Text] [Related]
6. Ion channels in cancer: future perspectives and clinical potential.
Lang F; Stournaras C
Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130108. PubMed ID: 24493756
[TBL] [Abstract][Full Text] [Related]
7. Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.
Milane L; Ganesh S; Shah S; Duan ZF; Amiji M
J Control Release; 2011 Oct; 155(2):237-47. PubMed ID: 21497176
[TBL] [Abstract][Full Text] [Related]
8. Functional properties of ion channels and transporters in tumour vascularization.
Fiorio Pla A; Munaron L
Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130103. PubMed ID: 24493751
[TBL] [Abstract][Full Text] [Related]
9. Ion channnels and transporters in cancer. 5. Ion channels in control of cancer and cell apoptosis.
Lehen'kyi V; Shapovalov G; Skryma R; Prevarskaya N
Am J Physiol Cell Physiol; 2011 Dec; 301(6):C1281-9. PubMed ID: 21940667
[TBL] [Abstract][Full Text] [Related]
10. Drug retention, efflux, and resistance in tumor cells.
Krishan A; Fitz CM; Andritsch I
Cytometry; 1997 Dec; 29(4):279-85. PubMed ID: 9415409
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance: a role for cholesterol efflux pathways?
Liscovitch M; Lavie Y
Trends Biochem Sci; 2000 Nov; 25(11):530-4. PubMed ID: 11084360
[TBL] [Abstract][Full Text] [Related]
12. Ion channels and transporters in tumour cell migration and invasion.
Schwab A; Stock C
Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130102. PubMed ID: 24493750
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of multidrug resistance in oncology and hematology].
Petrini M; Galimberti S
Tumori; 1997; 83(5 Suppl):S17-20. PubMed ID: 9446254
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of apoptotic volume decrease and ionic movements in multidrug-resistant tumor cells: role of chloride channels.
Poulsen KA; Andersen EC; Hansen CF; Klausen TK; Hougaard C; Lambert IH; Hoffmann EK
Am J Physiol Cell Physiol; 2010 Jan; 298(1):C14-25. PubMed ID: 19846756
[TBL] [Abstract][Full Text] [Related]
16. ABC transporters and the hallmarks of cancer: roles in cancer aggressiveness beyond multidrug resistance.
Muriithi W; Macharia LW; Heming CP; Echevarria JL; Nyachieo A; Filho PN; Neto VM
Cancer Biol Med; 2020 May; 17(2):253-269. PubMed ID: 32587767
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of long non-coding RNA GHET1 promotes the development of multidrug resistance in gastric cancer cells.
Zhang X; Bo P; Liu L; Zhang X; Li J
Biomed Pharmacother; 2017 Aug; 92():580-585. PubMed ID: 28578256
[TBL] [Abstract][Full Text] [Related]
18. beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein.
Wu CH; Rastegar M; Gordon J; Safa AR
Oncogene; 2001 Oct; 20(48):7006-20. PubMed ID: 11704825
[TBL] [Abstract][Full Text] [Related]
19. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.
Mohammad IS; He W; Yin L
Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
